Syra Health Corp

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Syra Health Corp. operates as a medical technology company, which engages in developing end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The company was founded by Deepika Vuppalanchi and Sandeep Allam in 2020 and is headquartered in Carmel, IN.

CARMEL, Ind. , Sept. 29, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare consulting company with a mission to improve healthcare by providing innovative services and technology solutions, announced today the pricing of its upsized initial public offering (the "IPO") of 1,615,000 units ("Units") at a public offering price of $4.125 per unit, for gross proceeds of approximately $6.7 million, before deducting underwriting discounts and offering expenses.

Syra Health Corp. Announces Pricing of Upsized Initial Public Offering

News for Syra Health Corp Stock (SYRA)